These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1525998)

  • 1. Detecting testosterone administration.
    Catlin DH; Cowan DA
    Clin Chem; 1992 Sep; 38(9):1685-6. PubMed ID: 1525998
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of testosterone administration by increased ratio between serum concentrations of testosterone and 17 alpha-hydroxyprogesterone.
    Carlström K; Palonek E; Garle M; Oftebro H; Stanghelle J; Björkhem I
    Clin Chem; 1992 Sep; 38(9):1779-84. PubMed ID: 1526014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria to indicate testosterone administration.
    Kicman AT; Brooks RV; Collyer SC; Cowan DA; Nanjee MN; Southan GJ; Wheeler MJ
    Br J Sports Med; 1990 Dec; 24(4):253-64. PubMed ID: 2097025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and urinary markers of exogenous testosterone administration.
    Palonek E; Gottlieb C; Garle M; Björkhem I; Carlström K
    J Steroid Biochem Mol Biol; 1995 Oct; 55(1):121-7. PubMed ID: 7577715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone.
    Perry PJ; MacIndoe JH; Yates WR; Scott SD; Holman TL
    Clin Chem; 1997 May; 43(5):731-5. PubMed ID: 9166223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of self-administration of testosterone as an anabolic by determination of the ratio of urinary testosterone to urinary epitestosterone in adolescents].
    Dehennin L; Scholler R
    Pathol Biol (Paris); 1990 Nov; 38(9):920-2. PubMed ID: 2277724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm.
    Goebel C; Howe CJ; Ho KK; Nelson A; Kazlauskas R; Trout GJ
    Drug Test Anal; 2009 Nov; 1(11-12):511-7. PubMed ID: 20355166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary profile of androgen metabolites at different stages of pubertal development in a population of sporting male subjects.
    Dehennin L; Delgado A; Pérès G
    Eur J Endocrinol; 1994 Jan; 130(1):53-9. PubMed ID: 8124479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High doses of alcohol increase urinary testosterone-to-epitestosterone ratio in females.
    Karila T; Kosunen V; Leinonen A; Tähtelä R; Seppälä T
    J Chromatogr B Biomed Appl; 1996 Dec; 687(1):109-16. PubMed ID: 9001958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a ketoconazole suppression test for verifying testosterone administration in the doping control of athletes.
    Oftebro H; Jensen J; Mowinckel P; Norli HR
    J Clin Endocrinol Metab; 1994 Apr; 78(4):973-7. PubMed ID: 8157729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of competition stress on tests used to assess testosterone administration in athletes.
    Guezennec CY; Lafarge JP; Bricout VA; Merino D; Serrurier B
    Int J Sports Med; 1995 Aug; 16(6):368-72. PubMed ID: 7591387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and urinary markers of oral testosterone misuse by healthy men in presence of masking epitestosterone administration.
    Dehennin L; Pérès G
    Int J Sports Med; 1996 Jul; 17(5):315-9. PubMed ID: 8858400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular administration of 5 alpha-dihydrotestosterone heptanoate: changes in urinary hormone profile.
    Coutts SB; Kicman AT; Hurst DT; Cowan DA
    Clin Chem; 1997 Nov; 43(11):2091-8. PubMed ID: 9365393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on urine diols: controls and athletes with elevated testosterone/epitestosterone ratios.
    Aguilera R; Chapman TE; Starcevic B; Hatton CK; Catlin DH
    Clin Chem; 2001 Feb; 47(2):292-300. PubMed ID: 11159778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of administration of human chorionic gonadotrophin on criteria used to assess testosterone administration in athletes.
    Cowan DA; Kicman AT; Walker CJ; Wheeler MJ
    J Endocrinol; 1991 Oct; 131(1):147-54. PubMed ID: 1744555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of testosterone/epitestosterone ratio influential factors as determined in doping analysis.
    van de Kerkhof DH; de Boer D; Thijssen JH; Maes RA
    J Anal Toxicol; 2000 Mar; 24(2):102-15. PubMed ID: 10732948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Androstenedione, epitestosterone, testosterone and luteininizing hormone in the blood serum of steers before and after GnRH (Lutal) administration].
    Möstl E; Choi HS; Kruip TA; Bamberg E
    Zentralbl Veterinarmed A; 1983 Jun; 30(6):429-37. PubMed ID: 6415960
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormonal correlations in the polycystic ovary syndrome.
    Messina M; Milani P; Gentile L
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):31-5. PubMed ID: 3087390
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin and the polycystic ovary syndrome.
    Utiger RD
    N Engl J Med; 1996 Aug; 335(9):657-8. PubMed ID: 8687522
    [No Abstract]   [Full Text] [Related]  

  • 20. Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.
    Mazzarino M; Braganò MC; de la Torre X; Molaioni F; Botrè F
    Steroids; 2011 Nov; 76(12):1400-6. PubMed ID: 21745489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.